Time to be vigilant in contacts of leprosy for possible single-dose rifampicin
Saved in:
Main Authors: | Pugazhenthan Thangaraju, MD (Author), Hemasri Velmurugan, MBBS, MD (Author), Krishnapriya Neelambaran, MBBS, MD (Author), Sajitha Venkatesan, MBBS, MD (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
SGLT-2 inhibitors: Post infarction interventional effects
by: Pugazhenthan Thangaraju, et al.
Published: (2023) -
Final leprosy push: Out of society
by: Pugazhenthan Thangaraju, et al.
Published: (2018) -
Drug flibanserin-in hypoactive sexual desire disorder
by: Pugazhenthan Thangaraju, et al.
Published: (2022) -
Leprosy post-exposure prophylaxis with single-dose rifampicin (LPEP): an international feasibility programme
by: Jan Hendrik Richardus, ProfPhD, et al.
Published: (2021) -
Cost-effectiveness of a chemoprophylactic intervention with single dose rifampicin in contacts of new leprosy patients.
by: Willemijn J Idema, et al.
Published: (2010)